510(k) Report

510(k) · Cleared

Recalled · 2005

Accu-Chek Aviva System

K043474510(k) TraditionalCleared Apr 27, 2005132-day reviewClass II21 CFR 862.1345Recalls 10

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Corp. · LFR Glucose Dehydrogenase, Glucose

Cleared on Apr 27, 2005 as substantially equivalent to K010362 (Roche Diagnostics Corp., 2001) and 1 other predicate after a 132-day review. Its family tree reaches back 1 generation to 2001. 1 of the 66 devices in its family, counting itself, has a Class I recall. 63 later devices descend from it. It has been recalled 10 times.

Decided
Apr 27, 2005
Review
132 days
Class
Class II
Product code
LFR
Recalls
10
Predicates
2

Its longest line of descent runs back 1 generation to K010362 (2001). 2 ancestors in all. 63 later devices descend from it, 10 citing it directly. 1 of the 66 devices in this family, counting this one, has a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 2003: 1 other ancestor2011: 2 descendants cleared2009: 3 descendants cleared2016: 4 descendants cleared2013: 5 descendants cleared2006: 1 descendant cleared2008: 1 descendant cleared2012: 3 descendants cleared2007: 1 descendant cleared2015: 4 descendants cleared2017: 4 descendants cleared2014: 3 descendants cleared2018: 5 descendants cleared2023: 4 descendants cleared2022: 3 descendants cleared2020: 5 descendants cleared, 1 with a Class I recall12025: 5 descendants cleared2024: 3 descendants cleared2021: 2 descendants cleared2026: 5 descendants clearedK010362 · Accu-Chek Comfort Curve Test Strip · Roche Diagnostics Corp. · 2001 · recalled200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 10 descendants2 generations forward: 13 descendants3 generations forward: 5 descendants4 generations forward: 4 descendants5 generations forward: 2 descendants6 generations forward: 7 descendants7 generations forward: 9 descendants, 1 with a Class I recall18 generations forward: 5 descendants9 generations forward: 5 descendants10 generations forward: 2 descendants11 generations forward: 1 descendant K010362 · Accu-Chek Comfort Curve Test Strip · Roche Diagnostics Corp. · 2001 · recalled0+5+10
  1. Root · 1 generation backK010362 Accu-Chek Comfort Curve Test StripRoche Diagnostics Corp. · 2001 · Recalled
  2. This deviceK043474 Accu-Chek Aviva SystemRoche Diagnostics Corp. · 2005
  3. Descendant · cites it directly · 46 of its ownK060620 Accu-Chek Aviva Test StripsRoche Diagnostics Corp. · 2006 · Recalled
  4. Descendant · cites it directly · 44 of its ownK101299 Accu-Chek Aviva Plus Blood Glucose Monitoring SystemRoche Diagnostics · 2011
  5. Descendant · 2 generations on · 37 of its ownK111353 Accu-Check Combo SystemRoche Diagnostics · 2012 · Recalled
  6. Descendant · 3 generations on · 33 of its ownK141929 Accu-Chek Connect Diabetes Management AppRoche Diagnostics Corporation · 2015 · Recalled
  7. Descendant · 4 generations on · 32 of its ownK150910 ACCU-CHEK Connect Diabetes Management AppRoche Diabetes Care, Inc. · 2015 · Recalled

Showing 5 of 63 descendants. See all descendants

Descendants cleared per year

2006: 12007: 12008: 12009: 32011: 22012: 32013: 52014: 32015: 42016: 42017: 42018: 52020: 52021: 22022: 32023: 42024: 32025: 52026: 5
2006high 5 (2013) · low 0 (2010)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 63 · See all
  • K060620Accu-Chek Aviva Test StripsRoche Diagnostics Corp. · 2006 · cites it directly46descendants
  • K101299Accu-Chek Aviva Plus Blood Glucose Monitoring SystemRoche Diagnostics · 2011 · cites it directly44descendants
  • K111353Accu-Check Combo SystemRoche Diagnostics · 2012 · 2 generations on37descendants
  • K141929Accu-Chek Connect Diabetes Management AppRoche Diagnostics Corporation · 2015 · 3 generations on33descendants
  • K150910ACCU-CHEK Connect Diabetes Management AppRoche Diabetes Care, Inc. · 2015 · 4 generations on32descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K010362Accu-Chek Comfort Curve Test StripRoche Diagnostics Corp.20016
0 (this device)K043474Accu-Chek Aviva SystemRoche Diagnostics Corp.2005—
+1K060620Accu-Chek Aviva Test StripsRoche Diagnostics Corp.20061
+1K101299Accu-Chek Aviva Plus Blood Glucose Monitoring SystemRoche Diagnostics2011—
+2K111353Accu-Check Combo SystemRoche Diagnostics20123
+3K141929Accu-Chek Connect Diabetes Management AppRoche Diagnostics Corporation20151
+4K150910ACCU-CHEK Connect Diabetes Management AppRoche Diabetes Care, Inc.20156

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200310

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
200710
200810
200930
201120
201230
201350
201430
201540
201640
201740
201850
202051
202120
202230
202340
202430
202550
202650
FIG. 1 — Lineage of K043474, 2001–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K010362Accu-Chek Comfort Curve Test Strip
Summary page 1
…Classification name: 75, LER, Glucose dehydrogenase, glucose 3) Predicate We claim substantial equivalence to the ACCU-CHEK Advantage system, device K010362 and K032552. 4) Device The ACCU-CHEK Aviva system utilizes reagent test strips stored within a description desiccat…
Roche Diagnostics Corp.20016
*K032552Accu-Chek Advantage System
Summary page 1
…ication name: 75, LER, Glucose dehydrogenase, glucose 3) Predicate We claim substantial equivalence to the ACCU-CHEK Advantage system, device K010362 and K032552. 4) Device The ACCU-CHEK Aviva system utilizes reagent test strips stored within a description desiccated vial. A t…
Roche Diagnostics Corp.2003—

What descends from it? (63)

See all 63

10 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K060620Accu-Chek Aviva Test StripsRoche Diagnostics Corp.200646
K101299Accu-Chek Aviva Plus Blood Glucose Monitoring SystemRoche Diagnostics201144
K121679Accu-Chek Inform II Blood Glucose Monitoring SystemRoche Diagnostics20125
K160944ACCU-CHEK Guide Blood Glucose Monitoring SystemRoche Diabetes Care, Inc.20163
K081403Glucose Meter-Check Control Solution for Roche Accu-ChekBionostics, Inc.20082
K082965DS-a Blood Glucose Monitoring SystemAlliance International Co., Ltd.20091
K083628Glucodr Auto SystemAll Medicus Co., Ltd.20091
K123612Fdi Glucose Control Solution for Use with Accu-Chek AvivaFujirebio Diagnostics,Inc.20130
K110436Fdi Glucose Control Solution for AvivaFujirebio Diagnostics,Inc.20110
K082328Glucodr Plus System, Model Agm-3000All Medicus Co., Ltd.20090

Has anything in its family been recalled? (1 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Nov 9, 2005Not classifiedZ-0417-06OtherIncorrect patient blood glucose test results may be reported due to a software problem.
Nov 9, 2005Not classifiedZ-0418-06OtherIncorrect patient blood glucose test results may be reported due to a software problem.
Nov 9, 2005Not classifiedZ-0420-06OtherIncorrect patient blood glucose test results may be reported due to a software problem.
Nov 9, 2005Not classifiedZ-0419-06OtherIncorrect patient blood glucose test results may be reported due to a software problem.
Nov 9, 2005Not classifiedZ-0421-06OtherIncorrect patient blood glucose test results may be reported due to a software problem.
Nov 9, 2005Not classifiedZ-0425-06OtherIncorrect patient blood glucose test results may be reported due to a software problem.
Nov 9, 2005Not classifiedZ-0426-06OtherIncorrect patient blood glucose test results may be reported due to a software problem.
Nov 9, 2005Not classifiedZ-0422-06OtherIncorrect patient blood glucose test results may be reported due to a software problem.
Nov 9, 2005Not classifiedZ-0423-06OtherIncorrect patient blood glucose test results may be reported due to a software problem.
Nov 9, 2005Not classifiedZ-0424-06OtherIncorrect patient blood glucose test results may be reported due to a software problem.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K193483Basal-IQ TechnologyTandem Diabetes Care, Inc. · 2020 · 7 generations on · ◆ in the 2020 descendants bar of FIG. 11 Class I recall

What does this lineage say?

  • 1 of the 2 ancestors has a recall of any class.
  • Of its descendants, K060620 (Roche Diagnostics Corp., 2006) has gone furthest, with 46 descendants of its own.

How does its category compare?

All LFR devices

LFR Glucose Dehydrogenase, Glucose: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LFR

1in 2015

2007: 12009: 12011: 62012: 132013: 32014: 32015: 1
2007high 13 (2012) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LFR

161in 2014

2011: 296 days median2012: 152 days median2013: 212 days median2014: 161 days median
2007high 296 (2011) · low 152 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LFR

1in 2012

2007: 32008: 12009: 42011: 12012: 1
2007high 4 (2009) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LFR

827in 2025

2007: 23,8192008: 6,5842009: 10,8232010: 4,8652011: 3,8022012: 3,3412013: 3,8212014: 3,9602015: 3,3662016: 2,1452017: 1032018: 1082019: 1082020: 1322021: 1642022: 1012023: 1032024: 1712025: 827
2007high 23,819 (2007) · low 101 (2022)2025

MAUDE reports naming product code LFR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—323,819
20080—16,584
20091—410,823
20100—04,865
2011629613,802
20121315213,341
2013321203,821
2014316103,960
20151—03,366
20160—02,145
20170—0103
20180—0108
20190—0108
20200—0132
20210—0164
20220—0101
20230—0103
20240—0171
20250—0827
20260—0—

What is it indicated for?

The ACCU-CHEK® Aviva system is designed to quantitatively measure the concentration of glucose in capillary whole blood by persons with diabetes or by health care professionals for monitoring blood glucose in the home or health care facility. The device is intended for professional use and over-the-counter sale. Professionals may use the test strip to test capillary and venous blood samples; lay use is limited to capillary whole blood testing. Testing sites include traditional fingertip site along with palm, forearm, upper arm, thigh, and calf.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K043474: Accu-Chek Aviva System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K043474

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026